Digilab, BioVisioN, Invitrogen, Bruker, Biacore, Bio-Rad, Thermo Electron, LabCorp, Yale, BSI, AstraZeneca, NE BioGroup, Nonlinear | GenomeWeb

Digilab Acquires BioVisioN to Develop Disease-Management Products

Digilab announced this week that it has acquired peptide-profiler BioVisioN.

"We plan to integrate proprietary Digilab tools into research processes and ultimately disease management systems," said Digilab President David Giddings in a statement.

Financial details were not released.

BioVisioN patented the Peptidomics technology and Differential Peptide Display software for peptide biomarker discovery. It is based in Hannover, Germany.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.